
The current state of the clinical trial market in Russia.

After the Coast Hearing, IRBs Should Prepare for More Scrutiny by Focusing on Training, Education, and SOPs

Many Capabilities Need to Be Evaluated by the Sponsor or CRO When it Chooses a Central IRB

The public would be best served if both recognize their own questionable practices.

The latest eclinical software in the clinical trials industry.

All Stakeholders in Human Research Protection Would Benefit from a Cooperative Enterprise That Moves Forward Without Blame

IRBs Can Provide Education and Facilitate Better Relationships to Improve Research Compliance

IRBs Role Today










Speakers at DIA's 45th Annual Meeting discuss indepth the stumbling blocks of informed consent and potential solutions that may clear the way.

Don't miss the pressing topics in the biotechnology industry that presenters discussed this year at DIA's 45th Annual Meeting.

San Diego Convention Center welcomes a packed house, as U.S. meeting gets underway with California casualness.



GCP in China is coming along, but much more is needed.





